Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
OXFORD, England and BOSTON, Nov. 14, 2023 /PRNewswire/ — Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI... Read More →
Neurent Medical Announces New CPT Code® for Chronic Rhinitis Treatment Offering Significant Symptom Improvements
GALWAY, Ireland, Nov. 13, 2023 /PRNewswire/ — Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced a significant milestone for the chronic rhinitis market. The Centers for Medicare and Medicaid Services (CMS) has... Read More →
Houston Innovation Awards winners revealed at 2023 event
The winner of the Life Science Business category, honoring an innovative company within the health and medical industries designing a treatment or technology, is CellChorus, using AI to evaluate immune cell function and performance to improve the development and delivery... Read More →
Remote Medication Monitor Receives Funding from Rady Venture Fund featuring Cari Health
CARI Health enables clinicians to view medication levels in real-time and customize dosages for every patient he Rady Venture Fund, a student-assisted venture capital investment fund, established at the Rady School of Management in 2009 to support the school’s educational... Read More →
Avenda Health’s Revolutionary AI Mapping Tool for Prostate Cancer Achieves Landmark Category III CPT Code Designation
Reimbursement code improves access to personalized prostate cancer care with Avenda Health’s AI cancer mapping platform, Unfold AI™ CULVER CITY, Calif., Nov. 1, 2023 /PRNewswire/ — The American Medical Association (AMA) has announced its 2024 Current Procedural Terminology (CPT) code... Read More →
Inari Medical plans to buy LimFlow Medical for up to $415M
Inari Medical (NASDAQ: NARI)+ today announced a definitive agreement to purchase LimFlow Medical for up to $415 million. The deal comes just weeks after Paris-based LimFlow won FDA premarket approval (PMA) for its breakthrough system to treat chronic limb-threatening ischemia... Read More →
Access Vascular to Ramp Production With $22 Million Series C Financing
Funding to drive production scale-up and expansion of MIMIX™ biomaterial catheter portfolio, increased R&D BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications with its advanced biomaterial platform, today announced that it... Read More →
Nesa Medtech raises an undisclosed amount in Pre-Series A funding round
New Delhi [India], October 30: In a significant development, Nesa Medtech, a renowned deeptech medical device startup, announced the successful closure of an undisclosed amount in their Pre-Series A round of funding. The round, led by KITVEN Fund 3 Biotech,... Read More →
FDA clears non-invasive insomnia-treating device from Neurovalens
Neurovalens announced today that the FDA granted clearance to its Modius Sleep device for treating chronic insomnia. Belfast, Northern Ireland-based Neurovalens develops non-invasive neurotechnology. The company took part in the MedTech Innovator Accelerator program last year. Read More
AMA Issues CPT Code for EchoSure
CPT Code establishes a standard reimbursement pathway for the EchoSure System effective July 1, 2024 BALTIMORE, MD (October 30, 2023) – Sonavex, Inc., a privately held medical device company with ultrasound technologies that deliver quantitative blood flow and other critical... Read More →